• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MSB 1.47% 33.5¢

MESOBLAST LIMITED

Mesoblast Limited is an Australia-based is developing a range of late-stage product... Mesoblast Limited is an Australia-based is developing a range of late-stage product candidates derived from its proprietary mesenchymal lineage cell therapy technology platforms. The Company’s Remestemcel-L is mesenchymal lineage stromal cell product platform and is in late-stage development for treatment of systemic inflammatory diseases, including Pediatric steroid refractory acute Graft versus Host Disease (SR-aGVHD), acute respiratory distress syndrome (ARDS) and Biologic refractory inflammatory bowel disease. Its Rexlemestrocel-L is mesenchymal lineage precursor cell product platform and is in late-stage development for treatment of advanced chronic heart failure (CHF) and chronic low back pain (CLBP) due to degenerative disc disease. Two products are commercialized in Japan and Europe by the Company’s licensees, and it has a commercial partnership in Europe and China for certain Phase III assets.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MSB
Cell Therapy News/Articles
19:45 17K 6.5M
19:45 Last post  gavint66 Comments Created with Sketch.  17K  Views Created with Sketch.  6.5M 
MSB 13:49 4 1.5K
13:49 Last post  nippy Comments Created with Sketch.  4  Views Created with Sketch.  1.5K 
MSB
MESO Nasdaq update
79 80 81
13:16 4.8K 2.3M
TRENDING NEWS

BREAKING: RBA keeps interest rate on hold at 4.35% in line with expectations

NEWS
19 Mar 2024
13:16 Last post  dyode Comments Created with Sketch.  4.8K  Views Created with Sketch.  2.3M 
MSB 09:51 476 133K
09:51 Last post  Pronewbie Comments Created with Sketch.  476  Views Created with Sketch.  133K 
MSB 18/03/24 3 1.4K
18/03/24 Last post  gavint66 Comments Created with Sketch.  3  Views Created with Sketch.  1.4K 
MSB
Mesoblast Shareholder Class Action (VID268/2022) – Notice to Group Members
2 3
18/03/24 163 70K
18/03/24 Last post  col69 Comments Created with Sketch.  163  Views Created with Sketch.  70K 
MSB
MSB Charts
2
17/03/24 61 28K
17/03/24 Last post  gavint66 Comments Created with Sketch.  61  Views Created with Sketch.  28K 
MSB 16/03/24 151 41K
16/03/24 Last post  whytee Comments Created with Sketch.  151  Views Created with Sketch.  41K 

See All Discussions arrow Created with Sketch.

Timeline

Cleansing Notice
19 Mar 08:45
 
Appendix 2A
18 Mar 12:09
 
Proposed issue of securities - MSB
14 Mar 16:55
 
Mesoblast Completes Placement and Entitlement Offer
14 Mar 09:54
 
FDA Supports Accelerated Approval Pathway for Heart Failure
11 Mar 09:57
 
MSB Q2 Financial Results and Operational Highlights
29 Feb 08:54
 
View More arrow Created with Sketch.
(20min delay)
Last
33.5¢
Change
-0.005(1.47%)
Mkt cap ! $381.1M
Open High Low Value Volume
33.5¢ 34.5¢ 33.0¢ $1.368M 4.082M

Buyers (Bids)

No. Vol. Price($)
2 96774 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 157458 8
View Market Depth
Last trade - 16.10pm 19/03/2024 (20 minute delay) ?
Last
33.5¢
  Change
-0.005 ( 1.62 %)
Open High Low Volume
33.5¢ 34.0¢ 33.0¢ 925057
Last updated 15.59pm 19/03/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.